273 related articles for article (PubMed ID: 24835494)
41. Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B.
Aragri M; Alteri C; Battisti A; Di Carlo D; Minichini C; Sagnelli C; Bellocchi MC; Pisaturo MA; Starace M; Armenia D; Carioti L; Pollicita M; Salpini R; Sagnelli E; Perno CF; Coppola N; Svicher V
J Infect Dis; 2016 Jun; 213(12):1897-905. PubMed ID: 26908731
[TBL] [Abstract][Full Text] [Related]
42. Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern.
Inoue J; Ueno Y; Wakui Y; Niitsuma H; Fukushima K; Yamagiwa Y; Shiina M; Kondo Y; Kakazu E; Tamai K; Obara N; Iwasaki T; Shimosegawa T
J Viral Hepat; 2011 Mar; 18(3):206-15. PubMed ID: 20367795
[TBL] [Abstract][Full Text] [Related]
43. Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D.
Yıldız O; Aygen B; Demirtürk N; Demirdal T; Inan D; Yıldırmak T; Kantürk A; Tütüncü E;
World J Gastroenterol; 2011 Dec; 17(45):4987-92. PubMed ID: 22174548
[TBL] [Abstract][Full Text] [Related]
44. Serologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon.
Magoro T; Gachara G; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong P
Virol J; 2016 Oct; 13(1):178. PubMed ID: 27769271
[TBL] [Abstract][Full Text] [Related]
45. HBV epidemiology and genetic diversity in an area of high prevalence of hepatitis B in southern Brazil.
Paoli J; Wortmann AC; Klein MG; Pereira VRZB; Cirolini AM; Godoy BA; Fagundes NJR; Wolf JM; Lunge VR; Simon D
Braz J Infect Dis; 2018; 22(4):294-304. PubMed ID: 30092176
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan.
Suzuki F; Tsubota A; Arase Y; Suzuki Y; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Takagi K; Kumada H
Intervirology; 2003; 46(3):182-9. PubMed ID: 12867757
[TBL] [Abstract][Full Text] [Related]
47. Comparison between Elecsys HBsAg II and Architect assays for quantification of serum hepatitis B surface antigen in Chinese patients with chronic hepatitis B.
Liu WW; Wang AZ; Xie FY; Hu TT; Zhong Q; Huang S
Clin Lab; 2015; 61(1-2):141-7. PubMed ID: 25807647
[TBL] [Abstract][Full Text] [Related]
48. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
Cao XX; Li J; Qiu LM; Luo YW; Chen YH; Ran Y
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):641-4. PubMed ID: 19785947
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers.
Kitab B; El Feydi AE; Afifi R; Derdabi O; Cherradi Y; Benazzouz M; Rebbani K; Brahim I; Salih Alj H; Zoulim F; Trepo C; Chemin I; Ezzikouri S; Benjelloun S
J Infect; 2011 Jul; 63(1):66-75. PubMed ID: 21640384
[TBL] [Abstract][Full Text] [Related]
50. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
Mirandola S; Sebastiani G; Rossi C; Velo E; Erne EM; Vario A; Tempesta D; Romualdi C; Campagnolo D; Alberti A
Antiviral Res; 2012 Dec; 96(3):422-9. PubMed ID: 23026293
[TBL] [Abstract][Full Text] [Related]
51. The enrichment of HBV immune-escape mutations during nucleoside/nucleotide analogue therapy.
Shan M; Shen Z; Sun H; Zheng J; Zhang M
Antivir Ther; 2017; 22(8):717-720. PubMed ID: 28300730
[TBL] [Abstract][Full Text] [Related]
52. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping.
Ohishi W; Shirakawa H; Kawakami Y; Kimura S; Kamiyasu M; Tazuma S; Nakanishi T; Chayama K
J Med Virol; 2004 Apr; 72(4):558-65. PubMed ID: 14981758
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudine-resistant HBV reactivation following hepatitis B surface antigen seroconversion.
Gérolami R; Borentain P; Colson P; Norguet E; Gérolami A; Tamalet C
Liver Int; 2007 Dec; 27(10):1417-21. PubMed ID: 18036104
[TBL] [Abstract][Full Text] [Related]
54. Drug-resistant and immune-escape hepatitis B virus mutants, occult hepatitis B infection and coinfections in public hospital patients from Argentina.
Delfino CM; Giorgio M; García G; Puch SS; Outon E; Mathet VL
Virus Genes; 2021 Aug; 57(4):327-337. PubMed ID: 34091827
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin.
Gomes-Gouvêa MS; Pereira Soares Mdo C; Guedes de Carvalho Mello IM; Brito EM; Pereira Moia Lde J; Bensabath G; Nunes HM; Carrilho FJ; Pinho JR
Acta Trop; 2008 Jun; 106(3):149-55. PubMed ID: 18420172
[TBL] [Abstract][Full Text] [Related]
56. Monitoring of therapy in patients with chronic hepatitis B virus.
Arrese E; Basaras M; Blanco S; Ruiz P; Cisterna R
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):736-40. PubMed ID: 19550344
[TBL] [Abstract][Full Text] [Related]
57. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.
Hsu CW; Yeh CT; Chang ML; Liaw YF
Gastroenterology; 2007 Feb; 132(2):543-50. PubMed ID: 17258721
[TBL] [Abstract][Full Text] [Related]
58. [HBV gene variants and polymerse gene mutations in children with chronic hepatitis B in the course of the antiviral therapy].
Góra-Gebka M; Liberek A; Charmuszko U; Sikorska-Wiśniewska G; Szlagatys-Sidorkiewicz A; Korzon M; Bielawski K
Med Wieku Rozwoj; 2007; 11(4):367-71. PubMed ID: 18605187
[TBL] [Abstract][Full Text] [Related]
59. Viral features of lamivudine resistant hepatitis B genotypes A and D.
Zöllner B; Petersen J; Puchhammer-Stöckl E; Kletzmayr J; Sterneck M; Fischer L; Schröter M; Laufs R; Feucht HH
Hepatology; 2004 Jan; 39(1):42-50. PubMed ID: 14752821
[TBL] [Abstract][Full Text] [Related]
60. HBV mutations associated with lamivudine therapy.
Lapiński TW; Parfieniuk-Kowerda A; Trzos A; Jaroszewicz J; Kowalczuk O; Nikliński J; Flisiak R
Przegl Epidemiol; 2013; 67(4):611-6, 705-8. PubMed ID: 24741905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
